Phase 2, Parallel-Arm Study of MGCD265 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Activating Genetic Alterations in Mesenchymal-Epithelial Transition Factor January 18, 2017 Type of Cancer Lung Site Hackensack Sponsor Mirati Protocol Number 265-109 To Learn More Call (201)-510-0950
